Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
CNY 3.14
(4.67%)
CNY 3.14
(4.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | -6.19% |
| 2022 | 1.52 Billion CNY | -5.41% |
| 2021 | 1.61 Billion CNY | -17.66% |
| 2020 | 1.95 Billion CNY | -13.76% |
| 2019 | 2.26 Billion CNY | -35.9% |
| 2018 | 3.53 Billion CNY | 24.26% |
| 2017 | 2.84 Billion CNY | 17.09% |
| 2016 | 2.43 Billion CNY | 18.01% |
| 2015 | 2.06 Billion CNY | 142.89% |
| 2014 | 848.52 Million CNY | 5.82% |
| 2013 | 801.86 Million CNY | -1.98% |
| 2012 | 818.01 Million CNY | -6.17% |
| 2011 | 871.78 Million CNY | 0.79% |
| 2010 | 864.97 Million CNY | 95.75% |
| 2009 | 441.87 Million CNY | 7.9% |
| 2008 | 409.53 Million CNY | 12.99% |
| 2007 | 362.43 Million CNY | 12.58% |
| 2006 | 321.93 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.36 Billion CNY | 0.45% |
| 2024 Q3 | 1.35 Billion CNY | -0.78% |
| 2024 Q1 | 1.36 Billion CNY | -4.67% |
| 2023 Q3 | 1.41 Billion CNY | -1.14% |
| 2023 FY | 1.42 Billion CNY | -6.19% |
| 2023 Q1 | 1.49 Billion CNY | -2.13% |
| 2023 Q2 | 1.43 Billion CNY | -3.93% |
| 2023 Q4 | 1.42 Billion CNY | 0.92% |
| 2022 Q4 | 1.52 Billion CNY | 0.17% |
| 2022 Q2 | 1.47 Billion CNY | -5.85% |
| 2022 Q1 | 1.56 Billion CNY | -3.06% |
| 2022 FY | 1.52 Billion CNY | -5.41% |
| 2022 Q3 | 1.52 Billion CNY | 3.45% |
| 2021 Q2 | 1.77 Billion CNY | -8.78% |
| 2021 Q3 | 1.74 Billion CNY | -1.97% |
| 2021 Q4 | 1.61 Billion CNY | -7.47% |
| 2021 FY | 1.61 Billion CNY | -17.66% |
| 2021 Q1 | 1.94 Billion CNY | -0.49% |
| 2020 Q3 | 1.79 Billion CNY | -17.5% |
| 2020 Q4 | 1.95 Billion CNY | 8.71% |
| 2020 Q2 | 2.18 Billion CNY | -3.61% |
| 2020 FY | 1.95 Billion CNY | -13.76% |
| 2020 Q1 | 2.26 Billion CNY | -0.25% |
| 2019 Q3 | 4.42 Billion CNY | -0.81% |
| 2019 FY | 2.26 Billion CNY | -35.9% |
| 2019 Q1 | 3.58 Billion CNY | 1.27% |
| 2019 Q2 | 4.45 Billion CNY | 24.45% |
| 2019 Q4 | 2.26 Billion CNY | -48.72% |
| 2018 Q1 | 2.97 Billion CNY | 4.31% |
| 2018 FY | 3.53 Billion CNY | 24.26% |
| 2018 Q4 | 3.53 Billion CNY | 9.17% |
| 2018 Q3 | 3.24 Billion CNY | 0.48% |
| 2018 Q2 | 3.22 Billion CNY | 8.59% |
| 2017 Q2 | 2.56 Billion CNY | 0.76% |
| 2017 FY | 2.84 Billion CNY | 17.09% |
| 2017 Q1 | 2.54 Billion CNY | 4.64% |
| 2017 Q4 | 2.84 Billion CNY | 10.06% |
| 2017 Q3 | 2.58 Billion CNY | 0.9% |
| 2016 Q3 | 2.66 Billion CNY | 37.86% |
| 2016 Q4 | 2.43 Billion CNY | -8.77% |
| 2016 Q1 | 1.95 Billion CNY | -5.18% |
| 2016 FY | 2.43 Billion CNY | 18.01% |
| 2016 Q2 | 1.93 Billion CNY | -1.04% |
| 2015 Q2 | 897.89 Million CNY | 0.08% |
| 2015 Q3 | 900.48 Million CNY | 0.29% |
| 2015 FY | 2.06 Billion CNY | 142.89% |
| 2015 Q1 | 897.19 Million CNY | 5.74% |
| 2015 Q4 | 2.06 Billion CNY | 128.87% |
| 2014 Q3 | 791.35 Million CNY | 0.62% |
| 2014 Q4 | 848.52 Million CNY | 7.22% |
| 2014 FY | 848.52 Million CNY | 5.82% |
| 2014 Q1 | 782.08 Million CNY | -2.47% |
| 2014 Q2 | 786.44 Million CNY | 0.56% |
| 2013 Q4 | 801.86 Million CNY | 4.7% |
| 2013 Q1 | 775.61 Million CNY | -5.18% |
| 2013 Q3 | 765.84 Million CNY | 0.05% |
| 2013 Q2 | 765.49 Million CNY | -1.3% |
| 2013 FY | 801.86 Million CNY | -1.98% |
| 2012 Q4 | 818.01 Million CNY | -4.65% |
| 2012 FY | 818.01 Million CNY | -6.17% |
| 2012 Q3 | 857.87 Million CNY | 0.52% |
| 2012 Q2 | 853.39 Million CNY | 0.24% |
| 2012 Q1 | 851.38 Million CNY | -2.34% |
| 2011 Q2 | 860.52 Million CNY | -2.08% |
| 2011 Q1 | 878.79 Million CNY | 1.6% |
| 2011 Q3 | 822.26 Million CNY | -4.45% |
| 2011 FY | 871.78 Million CNY | 0.79% |
| 2011 Q4 | 871.78 Million CNY | 6.02% |
| 2010 Q3 | 839.32 Million CNY | -0.31% |
| 2010 FY | 864.97 Million CNY | 95.75% |
| 2010 Q4 | 864.97 Million CNY | 3.06% |
| 2010 Q2 | 841.94 Million CNY | -2.76% |
| 2010 Q1 | 865.85 Million CNY | 95.95% |
| 2009 FY | 441.87 Million CNY | 7.9% |
| 2009 Q4 | 441.87 Million CNY | 0.0% |
| 2009 Q2 | 412.61 Million CNY | 0.0% |
| 2008 FY | 409.53 Million CNY | 12.99% |
| 2007 FY | 362.43 Million CNY | 12.58% |
| 2006 FY | 321.93 Million CNY | 0.0% |